← Return to Respect the toxicity of medicines; do not take strong drugs lightly

Study · verified by the research team

Aristolochic acid-associated urothelial cancer in Taiwan

Chen CH, Dickman KG, Moriya M, et al.; Grollman AP · 2012 · Proceedings of the National Academy of Sciences USA 109(21): 8241–8246

https://doi.org/10.1073/pnas.1119920109

Molecular epidemiology linking Aristolochia herbal remedies to upper-tract urothelial carcinoma in Taiwan using DNA-adduct and TP53 mutation signatures.

Study details

DesignMolecular epidemiological study
Population151 upper-tract urothelial carcinoma patients; 25 renal cell carcinoma controls
OutcomeAristolactam-DNA adducts; TP53 mutation spectrum
FindingTP53 signature dominated by A:T→T:A transversions, identical to that of Balkan endemic nephropathy, implicating aristolochic acid exposure
LimitationsExposure history partly inferred from biomarkers
Certaintyhigh

Cited by (2)

Chapters (1)

Atlas entrys (1)